THROMBOTIC MICROANGIOPATHY

Clinical trials for THROMBOTIC MICROANGIOPATHY explained in plain language.

Never miss a new study

Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear

Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Cheap antioxidant could replace costly drugs for Post-Transplant blood disorder

Disease control Ongoing

This study tests whether N-acetylcysteine (NAC), a common antioxidant, can treat a severe blood clotting condition called TA-TMA that can happen after a stem cell transplant. About 44 adults who develop TA-TMA will receive NAC to see if it improves blood counts and organ function…

Matched conditions: THROMBOTIC MICROANGIOPATHY

Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

THROMBOTIC MICROANGIOPATHY

Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear

Cheap antioxidant could replace costly drugs for Post-Transplant blood disorder